Jiri Widimsky Jr
Overview
Explore the profile of Jiri Widimsky Jr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
998
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Petrak O, Kratka Z, Holaj R, Zitek M, Nguyen Nikrynova T, Klimova J, et al.
Hypertension
. 2023 Dec;
81(3):595-603.
PMID: 38152977
Background: Adrenaline-producing tumors are mostly characterized by a sudden release of catecholamines with episodic symptoms. Noradrenergic ones are usually less symptomatic and characterized by a continuous overproduction of catecholamines that...
2.
Cifkova R, Bruthans J, Wohlfahrt P, Krajcoviechova A, Sulc P, Jozifova M, et al.
J Cardiovasc Dev Dis
. 2023 Aug;
10(8).
PMID: 37623341
Severe hypercholesterolemia is associated with an increase in the risk of developing atherosclerotic cardiovascular disease. The aim of this analysis was to assess longitudinal trends in severe dyslipidemia (defined as...
3.
Kaushik S, Majtan B, Holaj R, Barucic D, Kolosova B, Widimsky Jr J, et al.
Diagnostics (Basel)
. 2022 Dec;
12(12).
PMID: 36553213
Primary aldosteronism (PA) is the most frequent cause of secondary hypertension. Early diagnoses of PA are essential to avoid the long-term negative effects of elevated aldosterone concentration on the cardiovascular...
4.
Cifkova R, Bruthans J, Strilchuk L, Wohlfahrt P, Krajcoviechova A, Sulc P, et al.
Front Cardiovasc Med
. 2022 Nov;
9:1033606.
PMID: 36440040
Background: Hypertension is the most common cardiovascular disease which substantially increases cardiovascular morbidity and mortality. Despite the broad availability of antihypertensive medication, control of hypertension is not satisfactory worldwide. Objective:...
5.
Kolosova B, Waldauf P, Wichterle D, Kvasnicka J, Zelinka T, Petrak O, et al.
Diagnostics (Basel)
. 2022 Nov;
12(11).
PMID: 36428866
The new clinical prediction score (SCORE) has been recently proposed for primary aldosteronism (PA) subtyping prior to adrenal vein sampling (AVS). This study aimed to compare that SCORE with previously...
6.
Petrak O, Haluzikova D, Klimova J, Zitek M, Holaj R, Michalsky D, et al.
Biomedicines
. 2022 Aug;
10(8).
PMID: 36009527
The overproduction of catecholamines in pheochromocytoma/paraganglioma (PPGL) induces a hypermetabolic state. The aim of this study was to evaluate the incidence of a hypermetabolic state and differences in substrate metabolism...
7.
Holaj R, Waldauf P, Wichterle D, Kvasnicka J, Zelinka T, Petrak O, et al.
Diagnostics (Basel)
. 2022 Jul;
12(7).
PMID: 35885622
Purpose: Adrenal venous sampling (AVS) performed to distinguish unilateral and bilateral primary aldosteronism (PA) is invasive and poorly standardized. This study aimed to identify non-invasive characteristics that can select the...
8.
Klimova J, Mraz M, Kratochvilova H, Lacinova Z, Novak K, Michalsky D, et al.
Biomedicines
. 2022 Mar;
10(3).
PMID: 35327387
Background: Brown adipose tissue (BAT) is a therapeutic target to combat obesity and related disorders. Pheochromocytoma and functional paraganglioma (PPGL) are associated with activated BAT due to catecholamine excess. Our...
9.
Zelinka T, Petrak O, Waldauf P, Zitek M, Holaj R, Forejtova L, et al.
J Hum Hypertens
. 2021 Oct;
36(6):510-516.
PMID: 34615973
Primary aldosteronism (PA) is the most frequent form of endocrine hypertension. Recently, frequent clinically significant adrenal insufficiency after adrenalectomy in subjects with PA has been reported, which may make the...
10.
Wohlfahrt P, Bruthans J, Krajcoviechova A, Sulc P, Linhart A, Filipovsky J, et al.
Eur J Intern Med
. 2020 Jun;
79:63-69.
PMID: 32534942
Background: Cardiovascular disease (CVD) followed by cancer are the two leading causes of death worldwide. SCORE charts have been recommended in Europe to identify individuals at increased CVD risk. However,...